EPHX1 and hepatocellular carcinoma: Proteomic studies on the composition of a 5-FU–resistant hepatoma cell line have shown that the plasma membrane protein EPHX1 (epoxide hydrolase 1) is closely linked to 5-FU resistance and can be used as a new drug target to improve the clinical prognosis of patients with HCC [82].